Literature DB >> 19568833

Answer to the comments by Eric J. Grant et al. in "Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors".

Masaru Miyao1, Tomoyuki Watanabe, Ryumon Honda, Yuichi Yamada.   

Abstract

Entities:  

Year:  2009        PMID： 19568833      PMCID： PMC2711885          DOI： 10.1007/s12199-009-0088-7

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN： 1342-078X            Impact factor:   3.674


× No keyword cloud information.
  5 in total

1.  Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers.

Authors:  Tomoyuki Watanabe; Masaru Miyao; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2008-07-05       Impact factor: 3.674

2.  137Cs concentration in soil samples from an early survey of Hiroshima atomic bomb and cumulative dose estimation from the fallout.

Authors:  K Shizuma; K Iwatani; H Hasai; M Hoshi; T Oka; M Okano
Journal:  Health Phys       Date:  1996-09       Impact factor: 1.316

3.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

4.  Radiosensitivity of atomic bomb survivors as determined with a micronucleus assay.

Authors:  S Ban; J B Cologne; S Fujita; A A Awa
Journal:  Radiat Res       Date:  1993-05       Impact factor: 2.841

5.  Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.

Authors:  Dale L Preston; Donald A Pierce; Yukiko Shimizu; Harry M Cullings; Shoichiro Fujita; Sachiyo Funamoto; Kazunori Kodama
Journal:  Radiat Res       Date:  2004-10       Impact factor: 2.841
  5 in total
  1 in total

1.  Cancer mortality among atomic bomb survivors exposed as children.

Authors:  Hitomi Goto; Tomoyuki Watanabe; Masaru Miyao; Hiromi Fukuda; Yuzo Sato; Yoshiharu Oshida
Journal:  Environ Health Prev Med       Date:  2011-10-25       Impact factor: 3.674
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.